Sam-A Pharm. Co. Ltd (009300.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7009300005

Price
13,210.00 KRW
Market cap
80.63 bn KRW
P/E (2025)
6.23
P/S (2025)
1.04
Dividend yield
6.43 %
Net margin
16.63 %
Return on equity (ROE)
5.67 %
Return on assets (ROA)
5.24 %

Sam-A Pharm. Co. Ltd financials

Fiscal year20242025
Revenue95.58 bn KRW77.80 bn KRW
Gross profit60.83 bn KRW46.36 bn KRW
Operating income24.47 bn KRW10.98 bn KRW
EBIT29.81 bn KRW16.47 bn KRW
Net income22.08 bn KRW12.94 bn KRW
Diluted EPS – continuing operations3,617.62 KRW2,120.12 KRW

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sam-A Pharm. Co. Ltd

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It also provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid concentration enhancement, endurance enhancement, and the supply of vitamins and minerals; and NOMA-F gummy, NOMA CHEWABLE tablet, and NOMA GOLD chewable tablet for growth promotion, enhancement of nutritional deficiency, and supply of vitamins. Sam-A Pharm. Co., Ltd was founded in 1945 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.